NCATOD.org
  • About
    • What We Do
      • Canon of Ethics
      • Advocacy
    • Leadership
      • NCATOD Officers
    • Message from the Chairperson
    • NCATOD Members
    • Nat’l Conference Scholarships
    • Contact Us
  • Blog
    • NCATOD Blog
  • Professional Development
    • NCATOD Conference
      • 2024 Conference
      • Past Conferences
        • 2023 Conference
        • 2022 NCATOD Conference
        • 2021 Conference
        • 2020 Conference
        • 2019 NCATOD Conference
        • 2018 NCATOD Conference
        • 2017 NCATOD Conference
        • 2016 NCATOD Conference
        • 2015 NCATOD Conference
        • 2014 NCATOD Conference
        • 2013 NCATOD Conference
  • MAT Nurse Network
    • Education
      • IRETA
      • NCNA
      • NCBON
    • Certification
    • Get Involved
      • NCNA
      • ANA
    • MAT Nurses Week!
    • MNN Contacts
  • Resources
    • For Families
    • Find a Provider
    • Links
    • Fact Sheets
    • FAQ
    • Glossary
  • Contact

Blog

AATOD Memorandum – Buprenorphine

Posted by NCATOD on April 24, 2013

Department of Health and Human Services Final Rule – Modification of Dispensing Restrictions of Buprenorphine and Buprenorphine Combination as Used in Approved Opioid Treatment Medications

Buprenorphine FRN Memo122712

Tweet Pin It

Posted in: AATOD

Leave a Comment (0) ↓

NCATOD Officers will be happy to answer your questions. Contact us:

Chairperson:
Kenny House

Vice-Chairperson:
Scott Luetgenau

Secretary:
Jessica Tighe

Treasurer:
MeLane Barber

Copyright © 2013-2019 North Carolina Association for the Treatment of Opioid Dependence. All rights reserved. -- Website Developed & Maintained By: Empowered Ideas